Company: FVN
Filing Date: 2025-05-30
Form Type: S-4/A
Source: 0001829126-25-004067
Chunk: 559

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-30
Form: S-4/A
Chunk 559
---
uant to FINRA Rule 5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the commencement of sales in this offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following September 13, 2024 except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.

As of March 31, 2025 and December 31, 2024,
as a result of closing of the IPO, the exercise of the Representative’s Over-Allotment Option and the sales of Placement Units
in the private placement, there were 7,544,000 ordinary shares issued and outstanding, including 5,750,000 ordinary shares subject to
possible redemption, which are classified as temporary equity, and 1,794,000 ordinary shares. 1,794,000 ordinary shares issued and outstanding,
consisting of 1,437,500 ordinary shares of founder shares, 299,000 ordinary shares from private placement and 57,500 ordinary shares
to the underwriter.

Rights

As of March 31, 2025 and December 31,
2024, there were 5,750,000 public rights included in the Public Units and 299,000 private rights include in the Placement Units outstanding.
There was no right attached to the Representative Shares. Except in cases where the Company is not the surviving company in a business
combination, each holder of a right will receive one-tenth (1/10) of an ordinary share (the “Rights”) upon consummation of
the initial business combination. In the event the Company will not be the surviving company upon completion of our initial business
combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth
(1/10) of a share of the Company underlying each right upon consummation of the business combination unless otherwise waived in the course
of the business combination. No fractional shares will be issued upon exchange of rights. No additional consideration will be required
to be paid by a holder of rights in order to receive its additional shares upon consummation of a business combination. Fractional shares
will either be rounded down to the nearest whole share or otherwise